Association between Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients with Chronic Kidney Disease and Acute Myocardial Infarction
Cardiorenal Medicine · 24.06.2026 · 16 (1) · 461-473
DOI: 10.1159/000553263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiorenal Medicine, online erschienen am 24.06.2026. Verfasst von Jing Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Renal Insufficiency, Chronic, Myocardial Infarction. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Patients with chronic kidney disease (CKD) are at a high risk of adverse outcomes after acute myocardial infarction (AMI); however, evidence on long-term outcomes after percutaneous coronary intervention (PCI) in this population remains limited.
Methods
This prospective cohort study, nested within the Kailuan Study, included patients with CKD who experienced AMI between 2006 and 2020. Participants were classified into PCI and non-PCI groups based on documented PCI receipt and were matched 1:2 on age and sex (452 PCI; 745 non-PCI). Follow-up began at the time of AMI diagnosis or PCI and continued until December 31, 2023. The primary outcome was all-cause mortality, with secondary outcomes being new-onset heart failure and CKD progression. Time-segmented Cox models were used for all-cause mortality, and standard Cox models were used for secondary outcomes.
Results
During follow-up, PCI receipt was associated with a lower risk of all-cause mortality compared with no PCI. The association was stronger during the first 5 years of follow-up (hazard ratio [HR], 0.34; 95% confidence interval [CI], 0.24–0.47) and was attenuated thereafter (HR, 0.73; 95% CI, 0.51–1.04). No significant associations were observed between PCI receipt and either new-onset heart failure (HR, 1.06; 95% CI, 0.72–1.57) or CKD progression (HR, 1.11; 95% CI, 0.72–1.71).
Conclusion
In patients with CKD and AMI, PCI was associated with lower all-cause mortality during the first 5 years of follow-up, with no significant differences in new-onset heart failure or CKD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, China.
- Department of Nephrology, Kailuan General Hospital, Tangshan, China.
- School of Clinical Medicine, Hebei North University, Diamond South Road, Zhangjiakou, China.
- Department of Rheumatic Disease, Kailuan General Hospital, Tangshan, China.
- Department of Cardiology, Kailuan General Hospital, Tangshan, China, drwusl@163.com.
- Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, China, xinzhou@tmu.edu.cn.
Zitieren
APA
Zhou, J., Li, J., Xu, Y., Wang, R., Cui, L., Yang, Q., Wu, S., & Zhou, X. (2026). Association between Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients with Chronic Kidney Disease and Acute Myocardial Infarction. Cardiorenal Medicine, 16(1), 461-473. https://doi.org/10.1159/000553263
Vancouver
Zhou J, Li J, Xu Y, Wang R, Cui L, Yang Q, et al. Association between Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients with Chronic Kidney Disease and Acute Myocardial Infarction. Cardiorenal Medicine. 2026;16(1):461-473. doi:10.1159/000553263
BibTeX
@article{Zhou2026,
author = {Zhou, Jing and Li, Junjuan and Xu, Yan and Wang, Ru and Cui, Liufu and Yang, Qing and Wu, Shouling and Zhou, Xin},
title = {Association between Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients with Chronic Kidney Disease and Acute Myocardial Infarction},
journal = {Cardiorenal Medicine},
year = {2026},
volume = {16},
number = {1},
pages = {461--473},
doi = {10.1159/000553263}
}
EUVIMED